Web Analytics

Investor Profile

Amgen

Amgen United States - Thousand Oaks, CA
INVESTOR

1 Disclosed Funding Rounds $112,000,000
9 Participating Investments




Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.

Invested In

Company Date Round Raised
  Neumora October, 17 ,2022 Series B $112,000,000
  ImmunoScape September, 26 ,2022 Unknown $14,000,000
  CancerIQ March, 04 ,2022 Series B $14,000,000
  Feldan Therapeutics June, 14 ,2023 Series B $16,500,000
  Generate:Biomedicines September, 18 ,2023 Series C $273,000,000
  ReCode Therapeutics September, 20 ,2023 Series B $50,000,000
  Culmination Bio December, 01 ,2023 Unknown $10,000,000
  Seismic Therapeutic December, 05 ,2023 Series B $121,000,000
  Quantinuum January, 17 ,2024 Unknown $300,000,000